FindTrial
Sign In

A Clinical Study to Assess the Effectiveness of Sarpagandha Extract Mansyadi Kwatha and Jaladhara Therapy in the Treatment of Essential Hypertension

An Open-Label Randomised Controlled Clinical Study to Evaluate the Efficacy of Sarpagandha Extract Mansyadi Kwatha and Jaladhara in the Management of Essential Hypertension - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/100964
Enrollment
30
Registered
2026-01-13
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension

Interventions

None listed

Sponsors

Rajiv Gandhi Government Post Graduate Ayurvedic College and Hospital Paprola Himachal Pradesh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: A. Patients of either gender aged 18-70 years suffering from stage-I hypertension will be included in trial. Stage-I of JNC 8 th report. Systolic - 140-159mm of Hg Diastolic - 90- 99mm of Hg B. Patients willing and able to participate for 45 days of duration.

Exclusion criteria

Exclusion criteria: A. Individuals not willing to undergo the clinical trial. B. Patients below age of 18 years and above 70 years of age. C. Patients with Systolic B.P more than or equal to 160 mm of Hg and Diastolic B.P more than or equal to 100 mm of Hg. D. All the patients of secondary hypertension. E. Women who are pregnant or lactating. F. Hypertension associated with target organ damage. G. Having evidence of malignancy. H. Patients suffering from depressive disorder or on anti- depressive drugs. I. Who have completed participation in any other clinical trial during the past six months. J. History of hypersensitivity to any of the trial drug or other ingredients. K. Any other condition which the principal investigator thinks may jeopardize the study.

Design outcomes

Primary

MeasureTime frame
To determine the efficacy of Sarpagandha extract, Mansyadi Kwatha and Jaladhara in the Management of Essential Hypertension.Timepoint: After every fifteen days till the end of the trial.—

Secondary

MeasureTime frame
To assess the clinical safety and untoward effect of Sarpagandha Extract, Mansyadi Kwatha and Jaladhara in the patients of Essential Hypertension. To compare the efficacy of Sarpagandha Extract, Mansyadi Kwatha and Jaladhara with Telmisartan in the Management of Essential Hypertension.Timepoint: After every fifteen days till the end of the trial—

Countries

India

Contacts

Public ContactNIPUN GUPTA

Rajiv Gandhi Government Post Graduate Ayurvedic College and Hospital Paprola

drmsony@gmail.com8219121014

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026